FDA-Approved Prostate Cancer Treatments
Approved prostate cancer drug treatments including formulations and usual dosing.
Approved prostate cancer drug treatments including formulations and usual dosing.
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
FDA-approved oral and injectable treatment options for breast cancer.
The FDA is working in close collaboration with global regulatory partners to evaluate the controls in place and publish guidance on preventing unacceptable levels of nitrosamine in drugs.
Biosimilars Mvasi and Kanjinti are now available in the United States.
Continued approval of Xpovio for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
The FDA has expanded the approval of Darzalex (daratumumab; Janssen Biotech) to include use in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
More marked increases in incidence observed from 2006 to 2013 than from 1973 to 2006.